Immunohistochemical Evaluation of Triple Markers (ER, PR and HER-2/neu) in Carcinoma of the Breast in the North of Iraq.

作者: Wahda Mohammed Taib Al-Nuaimy , Abeer Hashem Ahmed , Hatim Abd-AlMajeed Al-Nuaimy

DOI:

关键词:

摘要: assessed immunohistochemically on formalin fixed paraffin embedded tissue of tumor. The pattern expression the triple markers was divided into four groups. results these were correlated with age, tumor size, types and grade lymph node status. Results: Each hormonal receptors (ER PR) expressed in 63.3% cases, while HER-2/neu over found 18% cases. ER+, PR +and HER-2 /neu-ve 56.3% While immunonegative observed 25.8% mean age patients positive ER 57.4 years as opposed to 45.7 among lacking expression. 48 years, which is 10 younger than those who lack size tumors expressing both 3.7 cm versus 5.2 for Tumors strong tended be larger expression, sizes 4.9 4.3cm respectively. An inverse relationship between grading there a direct No statistical significant association detected hormone /neu cases one hand metastasis other hand. Conclusions: breast carcinoma. This associated young at presentation, large high histological In contrast, each statistically correlate histopathological typing,

参考文章(33)
Felicia Recăreanu, Elena Pirici, Claudia Valentina Georgescu, Cristiana Simionescu, Ductal invasive mammary carcinoma--clinicopathological prognostic factors related to immunohistochemical expression of hormonal receptors and Her2/neu oncoprotein. Romanian Journal of Morphology and Embryology. ,vol. 52, pp. 1059- 1064 ,(2011)
Martine Piccart-Gebhart, Gul Atalay, J.M. Nabholtz, Caroline Lohrisch, Node positive breast cancer Lippincott Williams Wilkins. pp. 107- 146 ,(2003)
P. Neven, B. Van Calster, I. Van den Bempt, S. Van Huffel, V. Van Belle, W. Hendrickx, J. Decock, H. Wildiers, R. Paridaens, F. Amant, K. Leunen, P. Berteloot, D. Timmerman, E. Van Limbergen, C. Weltens, W. Van den Bogaert, A. Smeets, I. Vergote, M. R. Christiaens, M. Drijkoningen, Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer. Breast Cancer Research and Treatment. ,vol. 110, pp. 153- 159 ,(2008) , 10.1007/S10549-007-9687-4
Maher A. Sughayer, Maha M. Al-Khawaja, Suleiman Massarweh, Mahmoud Al-Masri, Prevalence of hormone receptors and HER2/neu in breast cancer cases in Jordan Pathology & Oncology Research. ,vol. 12, pp. 83- 86 ,(2006) , 10.1007/BF02893449
Chandrika Rao, Immunohistochemical profile and morphology in triple - negative breast cancers. Journal of clinical and diagnostic research : JCDR. ,vol. 7, pp. 1361- 1365 ,(2013) , 10.7860/JCDR/2013/5823.3129
R. Colomer, M. Beltran, J. Dorcas, H. Cortes-Funes, J. Hornedo, V. Valentin, C. Vargas, C. Mendiola, E. Ciruelos, It Is Not Time to Stop Progesterone Receptor Testing in Breast Cancer Journal of Clinical Oncology. ,vol. 23, pp. 3868- 3869 ,(2005) , 10.1200/JCO.2005.05.203
Dana Carmen Zaha, Significance of immunohistochemistry in breast cancer. World journal of clinical oncology. ,vol. 5, pp. 382- 392 ,(2014) , 10.5306/WJCO.V5.I3.382
Masumi Yanagawa, Kenzo Ikemot, Shigeto Kawauchi, Tomoko Furuya, Shigeru Yamamoto, Masaaki Oka, Atunori Oga, Yukiko Nagashima, Kohsuke Sasaki, Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype. BMC Research Notes. ,vol. 5, pp. 376- 376 ,(2012) , 10.1186/1756-0500-5-376